Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Dearnaley

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Frontiers of Radiation Therapy and Oncology|January 5, 2002
Intensity-modulated radiotherapy reduces lung irradiation in patients with carcinoma of the oesophagusChristopher M Nutting, James L Bedford, Vivian P Cosgrove, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2016
Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancerJames L Bedford, Gregory Smyth, Ian M Hanson, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods usedAntigoni Divoli, Gemma Bloch, Sarah Chittenden, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2010
Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillanceRamachandran Venkitaraman, Karen Thomas, Phillip Grace, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2006
A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancerA Rollo Moore, A P Jim Warrington, Edwin G A Aird, et al.
Cancer|March 29, 2002
Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal massesWilliam F Hendry, Andrew R Norman, David P Dearnaley, et al.
International Urology and Nephrology|February 7, 2008
Clinical implications of introducing a new PSA assayRamachandran Venkitaraman, Andrew R Norman, Jhangir Iqbal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2007
Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancerStephen A Mangar, Erica Scurr, Robert A Huddart, et al.
The British Journal of Radiology|August 7, 2015
Magnitude of observer error using cone beam CT for prostate interfraction motion estimation: effect of reducing scan length or increasing exposureHelen A McNair, Emma J Harris, Vibeke N Hansen, et al.
BJU International|February 14, 2006
Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancerVedang Murthy, Andrew R Norman, Mehdi Shahidi, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Frontiers of Radiation Therapy and Oncology|January 5, 2002
Intensity-modulated radiotherapy reduces lung irradiation in patients with carcinoma of the oesophagusChristopher M Nutting, James L Bedford, Vivian P Cosgrove, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2016
Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancerJames L Bedford, Gregory Smyth, Ian M Hanson, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods usedAntigoni Divoli, Gemma Bloch, Sarah Chittenden, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2010
Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillanceRamachandran Venkitaraman, Karen Thomas, Phillip Grace, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2006
A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancerA Rollo Moore, A P Jim Warrington, Edwin G A Aird, et al.
Cancer|March 29, 2002
Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal massesWilliam F Hendry, Andrew R Norman, David P Dearnaley, et al.
International Urology and Nephrology|February 7, 2008
Clinical implications of introducing a new PSA assayRamachandran Venkitaraman, Andrew R Norman, Jhangir Iqbal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2007
Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancerStephen A Mangar, Erica Scurr, Robert A Huddart, et al.
The British Journal of Radiology|August 7, 2015
Magnitude of observer error using cone beam CT for prostate interfraction motion estimation: effect of reducing scan length or increasing exposureHelen A McNair, Emma J Harris, Vibeke N Hansen, et al.
BJU International|February 14, 2006
Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancerVedang Murthy, Andrew R Norman, Mehdi Shahidi, et al.
Pageof 15